The drug candidate shows promise in filling existing therapeutic gaps. An experimental new drug has been shown to reduce cell damage, inflammation and organ damage linked to diabetes. In research led by scientists at NYU Langone Health, tests in mice revealed that the potential treatment blocks two proteins, RAGE and DIAPH1, from interacting. This specific […]
